Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16647870rdf:typepubmed:Citationlld:pubmed
pubmed-article:16647870lifeskim:mentionsumls-concept:C0029408lld:lifeskim
pubmed-article:16647870lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:16647870lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:16647870lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:16647870lifeskim:mentionsumls-concept:C0008466lld:lifeskim
pubmed-article:16647870lifeskim:mentionsumls-concept:C0017718lld:lifeskim
pubmed-article:16647870lifeskim:mentionsumls-concept:C1516048lld:lifeskim
pubmed-article:16647870pubmed:issue1lld:pubmed
pubmed-article:16647870pubmed:dateCreated2007-6-12lld:pubmed
pubmed-article:16647870pubmed:abstractTextThirty-five dogs were included in a randomised, double-blind, positive controlled, multi-centre trial to assess the efficacy of an orally-administered glucosamine hydrochloride and chondroitin sulfate (Glu/CS) combination for the treatment of confirmed osteoarthritis of hips or elbows. Carprofen was used as a positive control. Dogs were re-examined on days 14, 42 and 70 after initiation of treatment. Medication was then withdrawn and dogs were re-assessed on day 98. Response to treatment was based on subjective evaluation by participating veterinarians who recorded their findings at each visit. Dogs treated with Glu/CS showed statistically significant improvements in scores for pain, weight-bearing and severity of the condition by day 70 (P<0.001). Onset of significant response was slower for Glu/CS than for carprofen-treated dogs. The results show that Glu/CS has a positive clinical effect in dogs with osteoarthritis.lld:pubmed
pubmed-article:16647870pubmed:languageenglld:pubmed
pubmed-article:16647870pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16647870pubmed:citationSubsetIMlld:pubmed
pubmed-article:16647870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16647870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16647870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16647870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16647870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16647870pubmed:statusMEDLINElld:pubmed
pubmed-article:16647870pubmed:monthJullld:pubmed
pubmed-article:16647870pubmed:issn1090-0233lld:pubmed
pubmed-article:16647870pubmed:authorpubmed-author:MooneyCarmelClld:pubmed
pubmed-article:16647870pubmed:authorpubmed-author:McAllisterHes...lld:pubmed
pubmed-article:16647870pubmed:authorpubmed-author:JonesBoydBlld:pubmed
pubmed-article:16647870pubmed:authorpubmed-author:McCarthyGrain...lld:pubmed
pubmed-article:16647870pubmed:authorpubmed-author:O'DonovanJame...lld:pubmed
pubmed-article:16647870pubmed:authorpubmed-author:SeedMichaelMlld:pubmed
pubmed-article:16647870pubmed:issnTypePrintlld:pubmed
pubmed-article:16647870pubmed:volume174lld:pubmed
pubmed-article:16647870pubmed:ownerNLMlld:pubmed
pubmed-article:16647870pubmed:authorsCompleteYlld:pubmed
pubmed-article:16647870pubmed:pagination54-61lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:meshHeadingpubmed-meshheading:16647870...lld:pubmed
pubmed-article:16647870pubmed:year2007lld:pubmed
pubmed-article:16647870pubmed:articleTitleRandomised double-blind, positive-controlled trial to assess the efficacy of glucosamine/chondroitin sulfate for the treatment of dogs with osteoarthritis.lld:pubmed
pubmed-article:16647870pubmed:affiliationDepartment of Small Animal Clinical Studies, School of Agriculture, Food Science and Veterinary Medicine, College of Life Sciences, UCD Dublin, Belfield, Dublin 4, Ireland. grainne.mccarthy@ucd.ielld:pubmed
pubmed-article:16647870pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16647870pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:16647870pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16647870lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16647870lld:pubmed